A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Clinical trial NCT02182063 · COMPLETED

Trial details

NCT number: NCT02182063
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2005-11-01
Primary completion: 2007-01-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.